Search result for Phase I Study
First Patient Dosed in Phase I Study of SCB-313 for MPE by Clover Biopharmaceuticals
International clinical-stage biotechnology engaged in generating new and transformative biologic treatments, Clover Biopharmaceuticals publicized today how they had dosed their first patient in a Phase I trial of SCB-313 in Australia for treating cancer patients having malignant pleural effusions...